STOCK TITAN

AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AngioDynamics, Inc. (ANGO) announced participation in Oppenheimer conference for discussing healthcare and medtech innovations. The company aims to enhance blood flow, cancer treatments, and patient well-being.
Positive
  • None.
Negative
  • None.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Oppenheimer 34th Annual Virtual Healthcare MedTech & Services Conference at 12:40 p.m. ET on Tuesday, March 12, 2024.

A live webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

Investors:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics, Inc. participate in the Oppenheimer conference?

AngioDynamics, Inc. will participate in the Oppenheimer conference on Tuesday, March 12, 2024, at 12:40 p.m. ET.

Who will be representing AngioDynamics, Inc. at the conference?

Jim Clemmer, President and CEO, and Stephen Trowbridge, EVP and CFO, will represent AngioDynamics, Inc. at the conference.

Where can the live webcast of the fireside chat be accessed?

The live webcast of the fireside chat can be accessed through the 'Investors' section of AngioDynamics, Inc.'s website at www.angiodynamics.com.

Will the webcast be available for replay after the event?

Yes, the webcast of the fireside chat will be available for replay following the event.

AngioDynamics, Inc.

NASDAQ:ANGO

ANGO Rankings

ANGO Latest News

ANGO Stock Data

248.34M
38.86M
5%
91.34%
5.65%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
LATHAM

About ANGO

founded in 1988 in queensbury, n.y., u.s., angiodynamics is today a nasdaq-listed public company. we are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. our diverse product line includes market-leading radiofrequency ablation and nanoknife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. angiodynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. angiodynamics believes it is well poised to continue that trend. looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patie